The inflammatory linear verrucose epidermal nevus is a recently individualized special type of linear nevus. The particular features of this nevus are represented clinically by the pruritus and the erythematous, scaly, at times psoriasiform and frequently lichenifled aspect of the papulokeratotic lesions. Histologically, this disease is characterized by a psoriasiform picture or that of chronic eczema with, in some instances, the alternation of areas of agranulosis and hypergranulosis accompanied, respectively, by overlying parakeratosis and orthokeratosis. These areas are very sharply separated. The authors report a case and discuss the clinical and histologic criteria which justify the autonomy of this nevus, as well as the differential diagnosis, the etiopathogenesis, its relation to the ‘epidermal nevus syndrome’ of Solomon et al. and its treatment.

Keywords:
Nævus épidermique verruqueux inflammatoire linéaire (nevit), Prurit, Erythème, Psoriasis linéaire, Névrodermite linéaire
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.